MENU
CVAR
ETF ticker: BATS
PRICE
CHANGE
NET ASSETS

CVAR stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Mid-Cap Value
CVAR
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for CVAR with price predictions
Oct 01, 2026

CVAR's Stochastic Oscillator sits in oversold zone for 17 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for CVAR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

CVAR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CVAR as a result. In 57 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.

The Moving Average Convergence Divergence Histogram (MACD) for CVAR turned negative on August 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 30 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.

CVAR moved below its 50-day moving average on September 24, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CVAR crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVAR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

The Aroon Indicator for CVAR entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), Salesforce (NYSE:CRM), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Newmont Corp (NYSE:NEM), Lockheed Martin Corp (NYSE:LMT), BP plc (NYSE:BP), Medtronic plc (NYSE:MDT), CVS HEALTH Corp (NYSE:CVS), Accenture PLC (NYSE:ACN).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed exchange traded fund (“ETF”) that seeks to build a portfolio of approximately 50 to 100 securities across a broad spectrum of market capitalizations and sectors. To achieve its investment objective, it invests primarily in equity securities traded on U.S. exchanges of any size that the fund’s investment adviser, Cultivar Capital, Inc. (the “Adviser”), believes are under-valued, or under-appreciated, by other participants in the broader equity market. The fund is non-diversified.

Market Cap

The average market capitalization across the Cultivar ETF (CVAR) ETF is 73.68B. The market cap for tickers in the group ranges from 144.37M to 339.14B. UNH holds the highest valuation in this group at 339.14B. The lowest valued company is INGN at 144.37M.

High and low price notable news

The average weekly price growth across all stocks in the Cultivar ETF (CVAR) ETF was 13%. For the same ETF, the average monthly price growth was 34%, and the average quarterly price growth was 139%. ACN experienced the highest price growth at 20%, while FMC experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the Cultivar ETF (CVAR) ETF was 13%. For the same stocks of the ETF, the average monthly volume growth was 36% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 38
P/E Growth Rating: 53
Price Growth Rating: 53
SMR Rating: 59
Profit Risk Rating: 85
Seasonality Score: 16 (-100 ... +100)
View a ticker or compare two or three
CVAR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MidCapValue

Category
Mid-Cap Value
Address
ETF Opportunities Trust
Phone
N/A
Web
N/A
CVAR's Stochastic Oscillator sits in oversold zone for 17 days